Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion type Assertion NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_head.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_provenance.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion evidence source_evidence_literature NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_provenance.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion SIO_000772 24465546 NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_provenance.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion wasDerivedFrom befree-2016 NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_provenance.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion wasGeneratedBy ECO_0000203 NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_provenance.